PL388214A1 - Zastosowanie kinazy adenylanowej do deagregacji i hamowania agregacji płytek krwi - Google Patents

Zastosowanie kinazy adenylanowej do deagregacji i hamowania agregacji płytek krwi

Info

Publication number
PL388214A1
PL388214A1 PL388214A PL38821409A PL388214A1 PL 388214 A1 PL388214 A1 PL 388214A1 PL 388214 A PL388214 A PL 388214A PL 38821409 A PL38821409 A PL 38821409A PL 388214 A1 PL388214 A1 PL 388214A1
Authority
PL
Poland
Prior art keywords
deaggregation
inhibition
application
platelet aggregation
adenylate kinase
Prior art date
Application number
PL388214A
Other languages
English (en)
Polish (pl)
Inventor
Michał Komoszyński
Bożena Studzińska
Original Assignee
Uniwersytet Mikołaja Kopernika
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Mikołaja Kopernika filed Critical Uniwersytet Mikołaja Kopernika
Priority to PL388214A priority Critical patent/PL388214A1/pl
Priority to PCT/PL2010/000043 priority patent/WO2010143985A1/fr
Publication of PL388214A1 publication Critical patent/PL388214A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL388214A 2009-06-08 2009-06-08 Zastosowanie kinazy adenylanowej do deagregacji i hamowania agregacji płytek krwi PL388214A1 (pl)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PL388214A PL388214A1 (pl) 2009-06-08 2009-06-08 Zastosowanie kinazy adenylanowej do deagregacji i hamowania agregacji płytek krwi
PCT/PL2010/000043 WO2010143985A1 (fr) 2009-06-08 2010-06-07 Utilisation de l'adénylate kinase assurant la désagrégation et empêchant l'agrégation des plaquettes sanguines

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL388214A PL388214A1 (pl) 2009-06-08 2009-06-08 Zastosowanie kinazy adenylanowej do deagregacji i hamowania agregacji płytek krwi

Publications (1)

Publication Number Publication Date
PL388214A1 true PL388214A1 (pl) 2010-12-20

Family

ID=42688025

Family Applications (1)

Application Number Title Priority Date Filing Date
PL388214A PL388214A1 (pl) 2009-06-08 2009-06-08 Zastosowanie kinazy adenylanowej do deagregacji i hamowania agregacji płytek krwi

Country Status (2)

Country Link
PL (1) PL388214A1 (fr)
WO (1) WO2010143985A1 (fr)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1173768A (fr) * 1980-10-09 1984-09-04 Kazuhiko Nagata Adenylate kinase et procede de production

Also Published As

Publication number Publication date
WO2010143985A1 (fr) 2010-12-16

Similar Documents

Publication Publication Date Title
HUS2500013I1 (hu) Nitrogén-tartalmú spiro-gyûrûs vegyület és ennek gyógyászati alkalmazása
EP3363797B8 (fr) Forme de dosage orale d'inhibiteurs de kinase régulant le signal d'apoptose
GB2494787B (en) Neuro-protective effects of adelostemma gracillimum and its isolated compounds
GB0818498D0 (en) Provision of inserts
EP2696683A4 (fr) Compositions et utilisations thérapeutiques d'inhibiteurs de la kinase epsilon liée à ikk et de la kinase 1 de liaison à tank
ZA201301329B (en) Novel compounds and compositions for the inhibition of nampt
IL221556A (en) Kinase inhibitors and their use in cancer drug preparation
IL218555A0 (en) Pi3 kinase inhibitors and uses thereof
SG10201601846VA (en) Rnai inhibition of alpha-enac expression
ZA201201366B (en) Heterocycic derivatives as inhibitors of glutaminyl cyclase
IL196307A0 (en) Inhibition of alpha-synuclein aggregation
EP2534145A4 (fr) Methodes therapeutiques et compositions impliquant l'inhibition de la kinase allosterique
IL218617A (en) Derivatives of pyridinylimidazolone for inhibition of 3pi kinases
ZA201304756B (en) Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
IL220187A0 (en) Inhibitors of sphingosine kinase
EP2774973A4 (fr) Composition de fluide de freinage comprenant du triazole et du thiadiazole
EP2658973A4 (fr) Arnsi destiné à l'inhibition de l'expression du hif1a et composition anticancéreuse contenant celui-ci
ZA201207945B (en) Salts of dexlansoprazole and their preparation
ZA201300012B (en) Synthesis and use of kinase inhibitors
ZA201300009B (en) Oral formulation of kinase inhibitors
PL388214A1 (pl) Zastosowanie kinazy adenylanowej do deagregacji i hamowania agregacji płytek krwi
GB0907120D0 (en) Inhibitors of IKK-ß serine-threonine protein kinase
ZA201209647B (en) Crystalline forms of kinase inhibitors
ZA201209648B (en) Crystalline forms of kinase inhibitors
HK1184156A (en) Synthesis and use of kinase inhibitors

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)